How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

14,352 results for

Antibiotics in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis

) Exclusion Criteria: Beta lactam allergy Pregnancy Age less than 18 years No respect of recommandations for antibiotics ( molecule and dosage) Person under legal protection Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03310606 Contacts Layout table (...) Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2017 Clinical Trials

182. New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea

New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. New (...) AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea (NABOGO) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03294395 Recruitment Status : Recruiting First Posted : September 27, 2017 Last Update Posted

2017 Clinical Trials

183. Evaluation of the Impact of Intravenous Antibiotics on Muscular Strength in Patients With Cystic Fibrosis.

the definition of Rosentein et al (1997), who undergo an intravenous antibiotic cure for an acute exacerbation or electively since we notice a decline of respiratory lung function Exclusion Criteria: orthopaedic conditions interfering with mobility or the assessment of skeletal muscle force, a pregnancy, a pulmonary graft a negative response for the informed consent. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact (...) Evaluation of the Impact of Intravenous Antibiotics on Muscular Strength in Patients With Cystic Fibrosis. Evaluation of the Impact of Intravenous Antibiotics on Muscular Strength in Patients With Cystic Fibrosis. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2017 Clinical Trials

184. Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics

Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics (FMT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03117582 Recruitment Status : Enrolling by invitation First Posted : April

2017 Clinical Trials

185. Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis

staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years to 60 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Age between 18-60 years CT confirmed uncomplicated acute appendicitis Ability to give informed consent Exclusion Criteria: Age under 18 or over 60 years Pregnancy or lactation Allergy to contrast media or iodine Allergy or contraindication to antibiotic (...) Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Antibiotics vs. Placebo in Acute

2017 Clinical Trials

186. Intrapartum Fever: Antibiotics Versus no Treatment

Fetal Diseases Pregnancy Complications Fetal Membranes, Premature Rupture Obstetric Labor Complications Placenta Diseases Anti-Bacterial Agents Antibiotics, Antitubercular Anti-Infective Agents Antitubercular Agents (...) Intrapartum Fever: Antibiotics Versus no Treatment Intrapartum Fever: Antibiotics Versus no Treatment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Intrapartum Fever: Antibiotics Versus no Treatment

2017 Clinical Trials

187. Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit

Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit (REANEUF) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03217721 Recruitment Status : Completed First Posted : July 14, 2017 Last Update Posted : October 2, 2017 Sponsor: University Hospital, Brest Information

2017 Clinical Trials

188. Effects of Nursing Staff on Empiric Antibiotic in Septic Shock

to the ICU with septic shock from between January 01, 2015 to February 29, 2016 Criteria Inclusion Criteria: age>18 years old sepsis Exclusion Criteria: pregnancy >80 years old. Contacts and Locations Go to No Contacts or Locations Provided More Information Go to Layout table for additonal information Responsible Party: Chun Pan, Principal Investigator, Southeast University, China ClinicalTrials.gov Identifier: Other Study ID Numbers: Nurse: empiric antibiotic First Posted: March 21, 2017 Last Update (...) Effects of Nursing Staff on Empiric Antibiotic in Septic Shock Effects of Nursing Staff on Empiric Antibiotic in Septic Shock - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effects of Nursing Staff

2017 Clinical Trials

189. Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection

Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03099863 Recruitment Status : Recruiting First Posted : April 4, 2017 Last Update Posted : November

2017 Clinical Trials

190. Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome

to prolonged duration) so that obligatory post-operative use of antibiotics should be warranted, patients with any immunosuppressive condition (including cytotoxic chemotherapy, chronic use of glucocorticoids, however excluding diabetes mellitus, renal failure and heart failure); malignancy, pregnancy and breastfeeding; hepatic cirrhosis; end stage renal disease (GFR<10 mL/min); known allergy to both antibiotic medications used in the study. Contacts and Locations Go to Information from the National (...) Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2017 Clinical Trials

191. Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial

with urinary catheter) pregnancy/ breastfeeding current self-medication with UU preparations e.g. z.B. Cystinol®, Uvalysat®, Arctuvan® antibiotic use in the last 7 days previous UTI in the past 2 weeks history of pyelonephritis contraindications for trial drugs serious diseases inability to understand trial Information current participation in another clinical trial or participation in another clinical trial within the last 4 weeks Contacts and Locations Go to Information from the National Library (...) Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail

2017 Clinical Trials

192. An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care

obstructive pulmonary disease exacerbation treated with antibiotics during the last 6 months Known pregnancy Severe immunodeficiency (untreated HIV infection with CD4 count < 200 cells/mm3, solid organ transplant receiver, neutropenia, treatment with corticosteroids with dose equivalent to 20 mg prednisone/day for > 28 Admission of the patient GP not available for performing study Patient unable to provide informed consent Contacts and Locations Go to Information from the National Library of Medicine (...) An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2017 Clinical Trials

193. Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation (PHARMECMO)

antibiotic therapy was instituted. An ECMO treatment before study enrollement was required. Criteria Inclusion Criteria: Age > 18 years Extra corporeal membrane oxygenation treatment Parenteral antibiotherapy for known or suspected sepsis Informed consent Exclusion Criteria: Refusal of participation Pregnancy Burned patient Steady state conditions not reached Non-intravenous administration of antibiotherapy Contacts and Locations Go to Information from the National Library of Medicine To learn more about (...) Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation (PHARMECMO) Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation (PHARMECMO) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2017 Clinical Trials

194. Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia

Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Biomarker Guided (...) Antibiotic Treatment in Community-Acquired Pneumonia (BIO-CAP) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03146182 Recruitment Status : Recruiting First Posted : May 9, 2017 Last Update Posted : May 10, 2017 See Sponsor

2017 Clinical Trials

195. Outpatient Treatment of Uncomplicated Diverticulitis With Either Antibiotic or Nonantibiotic Treatment

Outpatient Treatment of Uncomplicated Diverticulitis With Either Antibiotic or Nonantibiotic Treatment Outpatient Treatment of Uncomplicated Diverticulitis With Either Antibiotic or Nonantibiotic Treatment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Outpatient Treatment of Uncomplicated Diverticulitis With Either Antibiotic or Nonantibiotic Treatment (MUD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03146091

2017 Clinical Trials

196. Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates (PubMed)

investigating a cohort of 40 full-term vaginally delivered infants born after an uncomplicated pregnancy, 18 of which were born from mothers receiving IAP.Fecal samples were collected at 2, 10, 30, and 90 days of age. We analyzed the composition of the fecal microbiota during the first 3 months of life by 16S rRNA gene sequencing and quantified fecal short chain fatty acids by gas chromatography. The presence of genes for resistance to antibiotics was determined by PCR in the samples from 1-month-old (...) Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates Disturbances in the early establishment of the intestinal microbiota may produce important implications for the infant's health and for the risk of disease later on. Different perinatal conditions may be affecting the development of the gut microbiota. Some of them, such as delivery mode or feeding habits, have been

Full Text available with Trip Pro

2017 Microbiome

197. Morbidity in Pregnant Women Associated with Unverified Penicillin Allergies, Antibiotic Use, and Group B Streptococcus Infections (PubMed)

Morbidity in Pregnant Women Associated with Unverified Penicillin Allergies, Antibiotic Use, and Group B Streptococcus Infections The morbidity potentially associated with unverified penicillin allergy in pregnant women, with and without group B streptococcus (GBS) infections, is unknown. Penicillin allergy testing is safe during pregnancy but is done infrequently.To determine morbidity associated with antibiotic use in a large cohort of pregnant women, with and without an unverified history (...) of penicillin allergy, and with and without GBS.Retrospective. All pregnant women who delivered live infants in Kaiser Permanente Southern California between January 1, 2009, and December 31, 2014, were identified.Penicillin allergy status at delivery, delivery method, maternal and infant hospital utilization, peripartum antibiotic exposures, new antibiotic-associated adverse drug reactions, and new Clostridium difficile infections.There were 170,379 unique women who had 201,316 pregnancies during the study

Full Text available with Trip Pro

2017 The Permanente journal

198. Routine Use of Prophylactic Antibiotics during Laparoscopic Cholecystectomy Does Not Reduce the Risk of Surgical Site Infections. (PubMed)

is still popular in many clinical settings. We investigated this situation in our department.This randomized double-blind controlled study included 570 patients who underwent LC between March 2007 and February 2010. The exclusion criteria were antibiotic intake before surgery, steroid treatment, and the presence of pancreatitis, cholangitis, obstructive jaundice, cephalosporin allergy, or pregnancy. The patients were randomized into three groups. Group 1 (n = 193) received physiologic saline as placebo (...) Routine Use of Prophylactic Antibiotics during Laparoscopic Cholecystectomy Does Not Reduce the Risk of Surgical Site Infections. Laparoscopic cholecystectomy (LC) is the gold standard for the treatment of symptomatic gallbladder stones. As infections are rare in uncomplicated LC, it is widely accepted that prophylactic antibiotics need not be administered, and guidelines do not support routine antibiotic prophylaxis during elective LC. However, routine antibiotic prophylaxis for elective LC

2017 Surgical infections Controlled trial quality: uncertain

199. Interventions for preventing recurrent urinary tract infection during pregnancy. (PubMed)

Interventions for preventing recurrent urinary tract infection during pregnancy. Recurrent urinary tract infections (RUTI) are common in women who are pregnant and may cause serious adverse pregnancy outcomes for both mother and child including preterm birth and small-for-gestational-age babies. Interventions used to prevent RUTI in women who are pregnant can be pharmacological (antibiotics) or non-pharmacological (cranberry products, acupuncture, probiotics and behavioural modifications). So (...) far little is known about the best way to prevent RUTI in pregnant women.To assess the effects of interventions for preventing recurrent urinary tract infections in pregnant women.The primary maternal outcomes were RUTI before birth (variously defined) and preterm birth (before 37 weeks). The primary infant outcomes were small-for-gestational age and total mortality.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (8 June 2012) and reference lists of retrieved

Full Text available with Trip Pro

2012 Cochrane

200. Flowchart: Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium, Antenatal assessment and management

• Current systemic infection (requiring antibiotics or hospitalisation) • Antepartum haemorrhage • Surgical procedure in pregnancy Known Risk Factors • Single prior provoked VTE (not COCP related) • Asymptomatic thrombophilia (inherited or acquired) • Family history VTE • Family history VTE (but no personal history VTE) + thrombophilia (excluding antithrombin deficiency) • No personal or family history of VTE but significant laboratory thrombophilia • Antiphospholipid antibodies VTE/Thrombophilias (...) Flowchart: Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium, Antenatal assessment and management Great state. Great opportunity. Department of Health State of Queensland (Queensland Health) 2014 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Antenatal assessment and management of VTE prophylaxis High Risk Factors • Single prior unprovoked VTE • Single prior VTE pregnancy or COCP related • Single

2014 Queensland Health

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>